Učitavanje...
SAFETY OF LONG-TERM THERAPY WITH WARFARIN: HEMORRHAGE FREQUENCY AND CLINICAL PREDICTORS (results of a prospective 15-year follow-up)
Despite the long-term clinical experience, bleeding remains the greatest danger for patients taking vitamin K antagonists. Moreover, even the presence of risk factors for hemorrhagic complications in a patient should not be the only reason for cancelling anticoagulant therapy. The challenge in asses...
Spremljeno u:
Glavni autori: | , , , , |
---|---|
Format: | Artigo |
Jezik: | Russo |
Izdano: |
«REMEDIUM GROUP» Ltd.
2017-05-01
|
Serija: | Атеротромбоз |
Teme: | |
Online pristup: | https://www.aterotromboz.ru/jour/article/view/117 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|